15 research outputs found
Tenomodulin knockout mice exhibit worse late healing outcomes with augmented trauma-induced heterotopic ossification of Achilles tendon
Heterotopic ossification (HO) represents a common problem after tendon injury with no effective treatment yet being developed. Tenomodulin (Tnmd), the best-known mature marker for tendon lineage cells, has important effects in tendon tissue aging and function. We have reported that loss of Tnmd leads to inferior early tendon repair characterized by fibrovascular scaring and therefore hypothesized that its lack will persistently cause deficient repair during later stages. Tnmd knockout (Tnmdâ/â) and wild-type (WT) animals were subjected to complete Achilles tendon surgical transection followed by end-to-end suture. Lineage tracing revealed a reduction in tendon-lineage cells marked by ScleraxisGFP, but an increase in alpha smooth muscle actin myofibroblasts in Tnmdâ/â tendon scars. At the proliferative stage, more pro-inflammatory M1 macrophages and larger collagen II cartilaginous template were detected in this group. At the remodeling stage, histological scoring revealed lower repair quality in the injured Tnmdâ/â tendons, which was coupled with higher HO quantified by micro-CT. Tendon biomechanical properties were compromised in both groups upon injury, however we identified an abnormal stiffening of non-injured Tnmdâ/â tendons, which possessed higher static and dynamic E-moduli. Pathologically thicker and abnormally shaped collagen fibrils were observed by TEM in Tnmdâ/â tendons and this, together with augmented HO, resulted in diminished running capacity of Tnmdâ/â mice. These novel findings demonstrate that Tnmd plays a protecting role against trauma-induced endochondral HO and can inspire the generation of novel therapeutics to accelerate repair
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease
Estrogen receptor-positive breast cancer is a highly prevalent but heterogeneous disease among women. Advanced molecular stratification is required to enable individually most efficient treatments based on relevant prognostic and predictive biomarkers. First objective of our study was the hypothesis-driven discovery of biomarkers involved in tumor progression upon xenotransplantation of Luminal breast cancer into humanized mice. The second objective was the marker validation and correlation with the clinical outcome of Luminal breast cancer disease within the GeparTrio trial. An elevated mdm2 gene copy number was associated with enhanced tumor growth and lung metastasis in humanized tumor mice. The viability, proliferation and migration capacity of inherently mdm2 positive breast cancer cells in vitro were significantly reduced upon mdm2 knockdown or anti-mdm2 targeting. An mdm2 gain significantly correlated with a worse DFS and OS of Luminal breast cancer patients, albeit it was also associated with an enhanced preoperative pathological response rate. We provide evidence for an enhanced Luminal breast cancer stratification based on mdm2. Moreover, mdm2 can potentially be utilized as a therapeutic target in the Luminal subtype
Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injury.
peer reviewed[en] OBJECTIVE: The Fragile X mental retardation (FMR) syndrome is a frequently inherited intellectual disability caused by decreased or absent expression of the FMR protein (FMRP). Lack of FMRP is associated with neuronal degradation and cognitive dysfunction but its role outside the central nervous system is insufficiently studied. Here, we identify a role of FMRP in liver disease.
DESIGN: Mice lacking Fmr1 gene expression were used to study the role of FMRP during tumour necrosis factor (TNF)-induced liver damage in disease model systems. Liver damage and mechanistic studies were performed using real-time PCR, Western Blot, staining of tissue sections and clinical chemistry.
RESULTS: Fmr1null mice exhibited increased liver damage during virus-mediated hepatitis following infection with the lymphocytic choriomeningitis virus. Exposure to TNF resulted in severe liver damage due to increased hepatocyte cell death. Consistently, we found increased caspase-8 and caspase-3 activation following TNF stimulation. Furthermore, we demonstrate FMRP to be critically important for regulating key molecules in TNF receptor 1 (TNFR1)-dependent apoptosis and necroptosis including CYLD, c-FLIPS and JNK, which contribute to prolonged RIPK1 expression. Accordingly, the RIPK1 inhibitor Necrostatin-1s could reduce liver cell death and alleviate liver damage in Fmr1null mice following TNF exposure. Consistently, FMRP-deficient mice developed increased pathology during acute cholestasis following bile duct ligation, which coincided with increased hepatic expression of RIPK1, RIPK3 and phosphorylation of MLKL.
CONCLUSIONS: We show that FMRP plays a central role in the inhibition of TNF-mediated cell death during infection and liver disease
A Nonlinear systemic approach to genome analysis
La investigaciĂłn llevada a cabo ha tenido como objetivo fundamental la implementaciĂłn,
puesta a punto y anĂĄlisis preliminar de un procedimiento original
para la discriminación sistémica, de alta sensibilidad, de genomas o epigenomas
representativos de condiciones tipo.
Los resultados obtenidos, presentados en esta memoria, avalan el enfoque
sistémico propuesto, que se basa en dos conjeturas fundamentales: por una
parte la consideraciĂłn de que las dinĂĄmicas adaptativas a las que se ven sometidos
los Genomas pueden ser analizadas desde la Ăłptica de los Sistemas Complejos
Adaptativos y, en particular, desde el marco conceptual y metodolĂłgico
de las teorĂas que sobre Complejidad y Caos determinista han venido desarrollĂĄndose
durante los Ășltimos veinte años y que se han aplicado con Ă©xito en
otros campos. Por otra parte, la presunciĂłn de que las secuencias de ADN
pueden ser conceptualizadas como series temporales multivariantes no lineales
y ser tratadas como tales a nivel de modelos formales. Ello es posible porque
conceptualmente una serie temporal es en esencia una colecciĂłn ordenada de
valores observacionales relativos a una de las variables de estado del sistema.
No es la temporalidad en sentido estricto sino la ordinalidad de los datos lo que
determina su dimensiĂłn "temporal", de tal modo que para todo valor vi de la
variable considerada puede establecerse de manera unĂvoca el valor precedente
vvâ1 y el subsecuente vi+1.Tesis Univ. Granada. Programa Oficial de Doctorado en: BioquĂmica y BiologĂa Molecula
Challenges of palliative care in children with inborn metabolic diseases
Abstract Background Our objective was to evaluate children with metabolic diseases in paediatric palliative home care (PPC) and the process of decision-making. This study was conducted as single-centre retrospective cohort study of patients in the care of a large specialized PPC team. Results Between 01/2013 and 09/2016, 198 children, adolescents and young adults were in the care of our PPC team. Twenty-nine (14.6%) of these patients had metabolic conditions. Median age at referral was 2.6Â years (0â24), median duration of care 352Â days (3â2248) and median number of home visits 13 (1â80). Most patients are still alive (16; 55.2%). Median number of drugs administered was 5 (range 0â12), antiepileptics were given most frequently. Symptom burden was high in all children with metabolic disorders at referral and remained high throughout care. Predominant symptoms were gastrointestinal, respiratory and neurologic symptoms. Children with metabolic conditions, who were referred to PPC younger than 1 year of age had a shorter period of care and died earlier compared to those children, who were referred to PPC later in their lives (older than 10Â years of age). Eleven (37.9%) of the children initially had no resuscitation restrictions and 7 (53.8%) of those who died, did so on ICU. Conclusions About 15% of children with life-limiting conditions in PPC present with metabolic diseases. Symptom burden is high with neurologic, respiratory and gastrointestinal symptoms being the most frequent and most of those being difficult to treat. In these children, particular attention needs to be addressed to advance care planning
Additional file 3: of Challenges of palliative care in children with inborn metabolic diseases
Figure S3. Overview of the different medication (A) and care tool (B) categories. Children with intercurrent metabolic crises are shown in black and children without metabolic crises in grey. To enable the comparison, relative prescription frequencies are reported. (JPG 252 kb
Additional file 2: of Challenges of palliative care in children with inborn metabolic diseases
Figure S2. Comparison of signs and symptoms of children with intercurrent metabolic crises (black) and children without metabolic crises (grey) at the end of care (last 30ĂÂ days). P-values obtained from Wilcoxon rank sum tests with continuity correction are show on top. A) Comparison of overall signs and symptoms. B) Comparison of detailed respiratory symptoms. C) Comparison of detailed gastrointestinal symptoms. D) Comparison of detailed neurological symptoms. (JPG 159 kb
Additional file 1: of Challenges of palliative care in children with inborn metabolic diseases
Figure S1. Signs and symptoms of children with intercurrent metabolic crises (black) and children without metabolic crises (grey) at referral (first 30ĂÂ days of care). P-values obtained from Wilcoxon rank sum tests with continuity correction are show on top. A) Comparison of overall signs and symptoms. B) Comparison of detailed respiratory symptoms. C) Comparison of detailed gastrointestinal symptoms. D) Comparison of detailed neurological symptoms. (JPG 135 kb
Ex vivo expansion of lung cancerâderived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression
The cellular basis of the apparent aggressiveness in lung cancer is poorly understood but likely associated with functional or molecular features of disseminated cancer cells (DCCs). DCCs from epithelial cancers are mostly detected by antibodies directed against histogenetic markers such as cytokeratin or EpCAM. It has been argued that marker-negative metastatic founder cells might escape detection. We therefore used ex vivo sphere formation for functional detection of candidate metastasis founders. We generated cell suspensions from 199 LN samples of 131 lung cancer patients and placed them into non-adherent cell culture. Sphere formation was associated with detection of DCCs using EpCAM immunocytology and with significantly poorer prognosis. The prognostic impact of sphere formation was strongly associated with high numbers of EpCAM-positive DCCs and aberrant genotypes of expanded spheres. We also noted sphere formation in patients with no evidence of lymphatic spread, however such spheres showed infrequent expression of signature genes associated with spheres from EpCAM-positive samples and displayed neither typical lung cancer mutations (KRAS, TP53, ERBB1) nor copy number variations, but might be linked to disease progression >5âyears post curative surgery. We conclude that EpCAM identifies relevant disease-driving DCCs, that such cells can be expanded for model generation and that further research is needed to clarify the functional and prognostic role of rare EpCAM-negative sphere forming cells